Latest Features

Nutraceuticals May Benefit Patients Who Are Statin Intolerant

Nutraceuticals May Benefit Patients Who Are Statin Intolerant

Nutraceuticals may offer a solution to patients who cannot tolerate statins because of severe muscle pain.

Breathing New Life Into COPD and Asthma Therapy With Statins

Breathing New Life Into COPD and Asthma Therapy With Statins

Statins have anti-inflammatory and anti-oxidative effects, which could reduce exacerbations of both asthma and chronic obstructive pulmonary disease.

PCSK9 Inhibitor Alirocumab Associated With 75% Reduction in Apheresis

PCSK9 Inhibitor Alirocumab Associated With 75% Reduction in Apheresis

Among patients with heterozygous familial hypercholesterolemia, alirocumab was associated with a 75% reduction in lipoprotein apheresis compared with placebo.

Statins Limit Vaccine Efficacy of Influenza Strain

Statins Limit Vaccine Efficacy of Influenza Strain

Statin use modified vaccine effectiveness and influenza risk for A(H3N2) infection but not for A(H1N1).

Higher Vitamin D Levels May Related to Higher Total Cholesterol, HDL-C

Higher Vitamin D Levels May Related to Higher Total Cholesterol, HDL-C

Vitamin D may influence cardiovascular disease risk via its effect on lipid levels.

Considering Cardiovascular Risks of Antidiabetic Drugs

Considering Cardiovascular Risks of Antidiabetic Drugs

A review of current antidiabetic drug treatments available and their individual cardiovascular risk profiles.

PCSK9 Inhibitors: Breakthrough in LDL-C Reduction, But Comes at a Cost

PCSK9 Inhibitors: Breakthrough in LDL-C Reduction, But Comes at a Cost

PCSK9 inhibitors may offer hope to patients with familial hypercholesterolemia who cannot tolerate or achieve goal LDL-C levels with statins.

LATEST NEWS

FDA to Review Praluent as Potential Treatment for MACE Risk Reduction

FDA to Review Praluent as Potential Treatment for MACE Risk Reduction

The sBLA is supported by data from the Phase 3 ODYSSEY OUTCOMES trial which included 18,924 patients who had experienced an acute coronary syndrome (ACS) in the previous 12 months.

Familial Hypercholesterolemia Benefits From Genetic Screening

Familial Hypercholesterolemia Benefits From Genetic Screening

Genetic screening for familial hypercholesterolemia would improve the likelihood of a definitive diagnosis and may help clinicians choose the appropriate therapy for patients.

FDA Issues CRL Rejecting Waylivra Approval for Familial Chylomicronemia Syndrome

FDA Issues CRL Rejecting Waylivra Approval for Familial Chylomicronemia Syndrome

"We are extremely disappointed with the FDA's decision. We continue to feel strongly that Waylivra demonstrates a favorable benefit/risk profile in people with FCS," said Akcea CEO, Paula Soteropoulos.

Praluent Labeling Updated With Dosing for HeFH Patients Undergoing LDL Apheresis

Praluent Labeling Updated With Dosing for HeFH Patients Undergoing LDL Apheresis

The dosing recommendation was based on data from a double-blind, placebo-controlled study conducted in 62 patients with HeFH undergoing LDL apheresis.

Nutraceuticals May Benefit Patients Who Are Statin Intolerant

Nutraceuticals May Benefit Patients Who Are Statin Intolerant

Nutraceuticals may offer a solution to patients who cannot tolerate statins because of severe muscle pain.

Vitamin D Independently, Inversely Tied to Cholesterol in Children

Vitamin D Independently, Inversely Tied to Cholesterol in Children

Gene variants did not modify the associations of 25(OH)D with lipids.

Patient Connectivity Benefits Familial Chylomicronemia Syndrome

Patient Connectivity Benefits Familial Chylomicronemia Syndrome

Patients with familial chylomicronemia syndrome who were actively connected were also 3 times as likely to report "high" or "extremely high" motivation in managing their own health.

Idiopathic inflammatory myositis linked to statin exposure

In a case-control study, patients with histologically-confirmed idiopathic inflammatory myositis were more likely to report exposure to statin medications than population-matched controls.

Statin Prescribing Has Increased With Automated Patient Dashboard

Statin Prescribing Has Increased With Automated Patient Dashboard

Modest increase in statin prescribing with automated dashboard using active choice framing for primary care physicians.

Unfavorable Prepregnancy Lipid Levels Linked to Low Parity

Unfavorable Prepregnancy Lipid Levels Linked to Low Parity

Higher prepregnancy triglyceride levels and triglyceride high-density lipoprotein cholesterol ratios were linked to increased risk for one lifetime pregnancy.

Sign Up for Free e-Newsletters